ALLAKOS INC's ticker is ALLK and the CUSIP is 01671P100. A total of 127 filers reported holding ALLAKOS INC in Q2 2020. The put-call ratio across all filers is 0.79 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $24,000 | -41.5% | 4,139 | 0.0% | 0.00% | – |
| Q4 2021 | $41,000 | -90.6% | 4,139 | 0.0% | 0.00% | -100.0% |
| Q3 2021 | $438,000 | +24.1% | 4,139 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $353,000 | -25.7% | 4,139 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $475,000 | -18.0% | 4,139 | 0.0% | 0.00% | -33.3% |
| Q4 2020 | $579,000 | +71.8% | 4,139 | 0.0% | 0.00% | +50.0% |
| Q3 2020 | $337,000 | +13.5% | 4,139 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $297,000 | – | 4,139 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 4,887,932 | $29,914,000 | 34.73% |
| Logos Global Management LP | 5,936,666 | $36,332,000 | 4.47% |
| TCG Crossover Management, LLC | 1,643,500 | $10,058,000 | 3.02% |
| Vivo Capital, LLC | 4,120,134 | $25,215,000 | 2.78% |
| Ally Bridge Group (NY) LLC | 598,172 | $3,661,000 | 2.42% |
| Frazier Life Sciences Management, L.P. | 4,792,000 | $29,327,000 | 2.26% |
| NEA Management Company, LLC | 6,148,704 | $33,867,000 | 1.69% |
| COMMODORE CAPITAL LP | 1,643,500 | $10,058,000 | 1.62% |
| BVF INC/IL | 5,006,921 | $30,642,000 | 1.27% |
| Deep Track Capital, LP | 4,518,575 | $27,654,000 | 1.27% |